NYSEAMERICAN:CCEL Cryo-Cell International 10/15/2024 Earnings Report $4.95 -0.10 (-1.98%) As of 04:10 PM Eastern Earnings HistoryForecast Cryo-Cell International EPS ResultsActual EPS$0.13Consensus EPS $0.02Beat/MissBeat by +$0.11One Year Ago EPSN/ACryo-Cell International Revenue ResultsActual Revenue$8.07 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACryo-Cell International Announcement DetailsQuarterDate10/15/2024TimeTASConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Cryo-Cell International Earnings HeadlinesCord Blood Banking Leader Cryo-Cell Announces Cash DividendMay 9, 2025 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial ResultsApril 15, 2025 | uk.finance.yahoo.comNew Way of Trading Has Gone ViralImagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict the biggest stock jumps this spring, to the day, with 83% backtested accuracy. In 2024 alone, it would've pointed to gains of 250% in 38 days on (TTWO)… 101% in 10 days on (WSM)… 353% in 48 days on (AON) and more in studies.May 14, 2025 | InvestorPlace (Ad)Cryo-Cell price target lowered to $8.50 from $9 at MaximMarch 4, 2025 | markets.businessinsider.comCryo-Cell reports FY24 EPS 5c vs ($1.14) last yearMarch 2, 2025 | markets.businessinsider.comCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024February 28, 2025 | businesswire.comSee More Cryo-Cell International Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cryo-Cell International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cryo-Cell International and other key companies, straight to your email. Email Address About Cryo-Cell InternationalCryo-Cell International (NYSEAMERICAN:CCEL) engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.View Cryo-Cell International ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? Upcoming Earnings Copart (5/15/2025)NetEase (5/15/2025)Applied Materials (5/15/2025)Mizuho Financial Group (5/15/2025)National Grid (5/15/2025)Walmart (5/15/2025)Alibaba Group (5/15/2025)Deere & Company (5/15/2025)Palo Alto Networks (5/19/2025)PDD (5/20/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
